Aimei Health Technology (AFJK) Stock Price, News & Analysis

Company Overview

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Key Stats

• Today's Range: $12.01 to $12.40
• 50-Day Range: $11.74 to $34.02
• 52-Week Range: $6.75 to $130.37
• Volume: 2,946 shs
• Average Volume: 21,613 shs
• Market Capitalization: $39.67 million
• P/E Ratio: 208.62
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Aimei Health Technology Stock Analysis - MarketRank™

Aimei Health Technology scored higher than 10% of companies evaluated by MarketBeat, and ranked 236th out of 250 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Aimei Health Technology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Aimei Health Technology has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Aimei Health Technology is 208.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.19.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aimei Health Technology is 208.62, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 20.29.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.07% of the float of Aimei Health Technology has been sold short.

Short Interest Ratio / Days to Cover

Aimei Health Technology has a short interest ratio ("days to cover") of 0.07, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Aimei Health Technology has recently decreased by 2.18%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aimei Health Technology does not currently pay a dividend.

Dividend Growth

Aimei Health Technology does not have a long track record of dividend growth.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Aimei Health Technology this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for AFJK on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added Aimei Health Technology to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Aimei Health Technology insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.50% of the stock of Aimei Health Technology is held by insiders.

Percentage Held by Institutions

45.58% of the stock of Aimei Health Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 8/26/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Energy
• Industry: Oil, Gas & Consumable Fuels
• Sub-Industry: Coal & Consumable Fuels
• Current Symbol: NASDAQ:AFJK
• Previous Symbol: NASDAQ:AFJK
• CIK: 1979005
• Web: N/A
• Phone: 34-67-803-5200
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.06
• Trailing P/E Ratio: 208.62
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.06 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -10.19%
• Return on Assets: 2.00%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.52 per share
• Price / Cash Flow: 24.09
• Book Value: ($1.42) per share
• Price / Book: -8.81

Miscellaneous

• Outstanding Shares: 3,170,000
• Free Float: 3,087,000
• Market Cap: $39.67 million
• Optionable: N/A
• Beta: 0.90